As of Feb 12
| +1.67 / +3.09%|
The 23 analysts offering 12-month price forecasts for Teva Pharmaceutical have a median target of 74.00, with a high estimate of 100.00 and a low estimate of 63.00. The median estimate represents a +32.74% increase from the last price of 55.75.
The current consensus among 25 polled investment analysts is to Buy stock in Teva Pharmaceutical. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.